Alkermes Plc (ALKS) — Quality & forensics
As of 2026-09-18 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.
The Closelook module scores
- Valuation 22
- Quality 52
- Growth 45
- Balance sheet 86
- Cash quality 65
- Capital allocation 38
- Momentum 66
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the ALKS chart & overview · the earnings record
FAQ · from the current data · as of 2026-09-18
Quick answers
What is Alkermes Plc's Closelook quality reading?
The composite reads 53/100 across 7 modules, as of 2026-09-18: valuation 22, quality 52, growth 45, balance sheet 86, cash quality 65, capital allocation 38, momentum 66. Closelook scores are research diary readings, not ratings or investment advice.
What is Alkermes Plc's Altman Z-Score?
7.69, which sits in the safe zone (above 2.99) as of 2026-09-18. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Alkermes Plc's Piotroski F-Score?
6 of 8, as of 2026-09-18. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Alkermes Plc's Beneish M-Score indicate?
-3.54 — below the −1.78 manipulation-risk threshold, as of 2026-09-18. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelook universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- BHC.TO Bausch Health Companies Incindustry
- ALM.MC Almirall S.A.industry
- HCM.L HUTCHMED China Ltdindustry
- PRGO Perrigo Company PLCindustry
- VTRS Viatris Incindustry
- RDY Dr. Reddy’s Laboratories Ltd ADRindustry
- DMP.DE Dermapharm Holding SEindustry
- UTHR United Therapeutics Corporationindustry
- ZTS Zoetis Incindustry
- GALDY GALDERMA GROUP AGindustry
- ELAN Elanco Animal Healthindustry
- NBIX Neurocrine Biosciences Incindustry
- DXCM DexCom Incsector
- ARGX argenx NV ADRsector
- ONC BeiGene, Ltd.sector
- MEDP Medpace Holdings Incsector